pharma · Acute Schizophrenia · Schizophrenia · RVPH
REVIVA PHARMACEUTICALS HOLDINGS
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Reviva Pharmaceuticals is a pharma organization headquartered in Cupertino, USA. It trades on NYSE under ticker RVPH. Primary therapeutic focus areas include Acute Schizophrenia, Schizophrenia, Hereditary Corneal Dystrop
Cupertino, USA HQ
20 Employees
Public company Type
RVPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cupertino, USA
- Employees
- 20
- Programs
- 3
- Drugs
- 1
- Patents
- 28
RP5063
Phase 2 · small molecule · Acute Schizophrenia
RP5063 for Acute Schizophrenia is a Phase 2 program (small_molecule) at REVIVA PHARMACEUTICALS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Internal code RVP-20-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acute Schizophrenia
- Status
- completed
- Trials
- 1